10x Genomics is trading 10.21% lower at $67.87 as investors retreat from technology stocks amid concerns about AI spending and rising oil prices. - The Nasdaq was down 2.51%, while the S&P 500 fell 1.39%, reflecting broader risk-off pressure. - No clear company-specific announcement explaining the October 22 decline surfaced; the company’s investor news page listed no same-day item in the search results. - The move is best attributed to broad market sentiment, not a confirmed company catalyst.